Buy Dostarlimab-glxy injection 500mg/10ml in bulk from a trusted pharmaceutical exporter. High-quality Jemperli 500mg injection with global supply and regulatory support. dostarlimab-glxy-injection-500mg-10ml-exporter Dostarlimab-glxy injection 500mg/10ml Jemperli 500mg injection, dostarlimab injection supplier, oncology injection exporter, cancer immunotherapy injection, bulk pharmaceutical exporter Dostarlimab-glxy Injection 500mg/10ml – Jemperli 500mg Injection Exporter Reliable Supply of Advanced Immunotherapy for Global Oncology Markets Looking for bulk supply of Dostarlimab-glxy injection 500mg/10ml? Partner with a trusted pharmaceutical exporter delivering quality-assured oncology products with consistent global supply and regulatory support. Dostarlimab-glxy injection 500mg/10ml is a monoclonal antibody used in cancer immunotherapy, specifically designed to enhance the body’s immune response against tumor cells. Marketed as Jemperli 500mg injection, this product is widely used in advanced oncology treatments and is in demand among hospitals and oncology centers worldwide. Primecare Impex ensures reliable sourcing, strict quality control, and efficient export logistics to meet international pharmaceutical standards. Product Name: Jemperli 500mg Injection Generic Name: Dostarlimab-glxy Strength: 500 mg / 10 ml Dosage Form: Injection Packaging: 1 vial of 10 ml Shelf Life: 24 months Category: Oncology / Immunotherapy Route of Administration: Intravenous Dostarlimab-glxy injection 500mg/10ml Concentration: 50 mg/ml Dosage Form Sterile injectable solution for intravenous infusion Strength 500 mg per 10 ml vial Packaging 1 vial × 10 ml per pack (export-grade packaging available on request) Shelf Life 24 Months (stored under recommended conditions) Treatment of endometrial cancer Indicated for mismatch repair deficient (dMMR) tumors Used in advanced or recurrent solid tumors Cancer immunotherapy protocols Dostarlimab-glxy is a programmed death receptor-1 (PD-1) blocking antibody. It works by inhibiting the PD-1 pathway, thereby enhancing the immune system’s ability to detect and destroy cancer cells. This mechanism plays a critical role in improving immune response against tumors. Administered as an intravenous infusion Dosage schedule should be determined by an oncologist Typically given under strict clinical supervision Pre-medication and monitoring may be required Always follow prescribing physician guidelines and institutional protocols. For hospital and clinical use only Monitor for immune-related adverse reactions Use with caution in patients with autoimmune conditions Not recommended during pregnancy unless advised by a healthcare provider Requires proper cold-chain storage and handling Why Choose Primecare Impex Trusted oncology injection exporter with global reach Strict adherence to international quality standards Verified sourcing and documentation support Temperature-controlled logistics for sensitive products Dedicated support for bulk buyers and distributors Transparent communication and fast response time Global Export Capability Primecare Impex specializes in the export of high-value oncology and specialty medicines. We support importers, distributors, and institutional buyers with: Bulk supply of Dostarlimab-glxy injection 500mg/10ml Regulatory documentation assistance Customized packaging solutions Reliable logistics for international delivery Consistent supply chain for long-term partnerships Request Bulk Quote for Dostarlimab-glxy Injection 500mg/10ml Looking for a dependable supplier of Jemperli 500mg injection? Connect with our export team for competitive pricing and fast global delivery. 📞 WhatsApp: +91 9673008130 🌐 Website: www.medicineexporterfromindia.com Get a Quote Now | Bulk Orders Available | Global Shipping Support Oncology injections exporter Cancer immunotherapy medicines supplier Monoclonal antibody injections Pharmaceutical bulk export services Cold chain logistics for pharma exports